Gilead Sciences (GILD) PT Lowered to $168 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $123.76 --0%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 7 | New: 21
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 7 | New: 21
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on Gilead Sciences (NASDAQ: GILD) to $168.00 (from $175.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
- JPMorgan Upgrades Bangkok Bank PCL (BBL:TB) (BGKKF) to Overweight
- Promotora y Operadora de Infraestructura SAB de CV (PINFRA:MM) (PYOIF) PT Raised to Peso315 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
